{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T23:50:05Z","timestamp":1783986605428,"version":"3.55.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:00:00Z","timestamp":1710460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.omtn.2024.102174","type":"journal-article","created":{"date-parts":[[2024,3,17]],"date-time":"2024-03-17T06:22:19Z","timestamp":1710656539000},"page":"102174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Inhibition of miR-25 ameliorates cardiac and skeletal muscle dysfunction in aged mdx\/utrn haploinsufficient (+\/\u2212) mice"],"prefix":"10.1016","volume":"35","author":[{"given":"Sacha V.","family":"Kepreotis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Gyun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimeen","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cholong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Mercola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger J.","family":"Hajjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4153-3498","authenticated-orcid":false,"given":"Dongtak","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2024.102174_bib1","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/mus.24880","article-title":"Twenty-year follow-up of newborn screening for patients with muscular dystrophy","volume":"53","author":"Chung","year":"2016","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.omtn.2024.102174_bib2","doi-asserted-by":"crossref","first-page":"18168","DOI":"10.3390\/molecules201018168","article-title":"Duchenne Muscular Dystrophy: From Diagnosis to Therapy","volume":"20","author":"Falzarano","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.omtn.2024.102174_bib3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/mus.22097","article-title":"Cardiomyopathy of Duchenne muscular dystrophy: current understanding and future directions","volume":"44","author":"Spurney","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.omtn.2024.102174_bib4","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrcardio.2013.213","article-title":"Treatment of dystrophin cardiomyopathies","volume":"11","author":"Finsterer","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.omtn.2024.102174_bib5","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1161\/CIRCULATIONAHA.114.015151","article-title":"Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular Dystrophy","volume":"131","author":"McNally","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.omtn.2024.102174_bib6","doi-asserted-by":"crossref","first-page":"410","DOI":"10.4330\/wjc.v7.i7.410","article-title":"Cardiac involvement in Duchenne and Becker muscular dystrophy","volume":"7","author":"Mavrogeni","year":"2015","journal-title":"World J. Cardiol."},{"key":"10.1016\/j.omtn.2024.102174_bib7","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s11897-010-0028-2","article-title":"Cardiac assessment in duchenne and becker muscular dystrophies","volume":"7","author":"Romfh","year":"2010","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/j.omtn.2024.102174_bib8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1055\/s-0034-1398689","article-title":"Cardiomyopathy in Duchenne Muscular Dystrophy: Current Value of Clinical, Electrophysiological and Imaging Findings in Children and Teenagers","volume":"227","author":"Dittrich","year":"2015","journal-title":"Klin. P\u00e4diatr."},{"key":"10.1016\/j.omtn.2024.102174_bib9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/CIRCIMAGING.110.960740","article-title":"Cardiac involvement in patients with muscular dystrophies: magnetic resonance imaging phenotype and genotypic considerations","volume":"4","author":"Verhaert","year":"2011","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"10.1016\/j.omtn.2024.102174_bib10","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.nmd.2011.07.003","article-title":"Cardiac dysfunction and pathology in the dystrophin and utrophin-deficient mouse during development of dilated cardiomyopathy","volume":"22","author":"Chun","year":"2012","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtn.2024.102174_bib11","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.nmd.2012.05.002","article-title":"Cardiomyopathy in the dystrophin\/utrophin-deficient mouse model of severe muscular dystrophy is characterized by dysregulation of matrix metalloproteinases","volume":"22","author":"Delf\u00edn","year":"2012","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtn.2024.102174_bib12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1242\/dmm.018424","article-title":"Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy","volume":"8","author":"McGreevy","year":"2015","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.omtn.2024.102174_bib13","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1161\/CIRCRESAHA.113.301651","article-title":"Mechanisms of altered Ca(2)(+) handling in heart failure","volume":"113","author":"Luo","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.omtn.2024.102174_bib14","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s00424-014-1469-3","article-title":"Ca handling during excitation-contraction coupling in heart failure","volume":"466","author":"Zima","year":"2014","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.omtn.2024.102174_bib15","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1161\/CIRCULATIONAHA.106.654699","article-title":"Sarcoplasmic reticulum calcium overloading in junctin deficiency enhances cardiac contractility but increases ventricular automaticity","volume":"115","author":"Yuan","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.omtn.2024.102174_bib16","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/CIRCRESAHA.107.157552","article-title":"Modest reductions of cardiac calsequestrin increase sarcoplasmic reticulum Ca2+ leak independent of luminal Ca2+ and trigger ventricular arrhythmias in mice","volume":"101","author":"Chopra","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.omtn.2024.102174_bib17","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.bbrc.2003.09.005","article-title":"Decreased mAKAP, ryanodine receptor, and SERCA2a gene expression in mdx hearts","volume":"310","author":"Rohman","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omtn.2024.102174_bib18","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1479-5876-9-132","article-title":"SERCA2a gene transfer improves electrocardiographic performance in aged mdx mice","volume":"9","author":"Shin","year":"2011","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.omtn.2024.102174_bib19","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrg1379","article-title":"MicroRNAs: small RNAs with a big role in gene regulation","volume":"5","author":"He","year":"2004","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.omtn.2024.102174_bib20","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nature13073","article-title":"Inhibition of miR-25 improves cardiac contractility in the failing heart","volume":"508","author":"Wahlquist","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2024.102174_bib21","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1016\/j.ajpath.2011.02.024","article-title":"Inhibiting TGF-beta activity improves respiratory function in mdx mice","volume":"178","author":"Nelson","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtn.2024.102174_bib22","doi-asserted-by":"crossref","first-page":"H1685","DOI":"10.1152\/ajpheart.00266.2001","article-title":"Decreased Smad 7 expression contributes to cardiac fibrosis in the infarcted rat heart","volume":"282","author":"Wang","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.omtn.2024.102174_bib23","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/abbs\/gmp018","article-title":"Regulation of TGF-beta signaling by Smad7","volume":"41","author":"Yan","year":"2009","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.omtn.2024.102174_bib24","doi-asserted-by":"crossref","first-page":"H1550","DOI":"10.1152\/ajpheart.01253.2007","article-title":"Functional resolution of fibrosis in mdx mouse dystrophic heart and skeletal muscle by halofuginone","volume":"294","author":"Huebner","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.omtn.2024.102174_bib25","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.yjmcc.2013.07.014","article-title":"Coronary adventitial cells are linked to perivascular cardiac fibrosis via TGFbeta1 signaling in the mdx mouse model of Duchenne muscular dystrophy","volume":"63","author":"Ieronimakis","year":"2013","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.omtn.2024.102174_bib26","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.suronc.2013.01.003","article-title":"MicorRNA 106b approximately 25 cluster and gastric cancer","volume":"22","author":"Li","year":"2013","journal-title":"Surg. Oncol."},{"key":"10.1016\/j.omtn.2024.102174_bib27","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.canlet.2013.02.029","article-title":"MicroRNA-25 functions as a potential tumor suppressor in colon cancer by targeting Smad7","volume":"335","author":"Li","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.omtn.2024.102174_bib28","doi-asserted-by":"crossref","first-page":"5162","DOI":"10.1038\/onc.2012.11","article-title":"The miR-106b-25 cluster targets Smad7, activates TGF-beta signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer","volume":"31","author":"Smith","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.omtn.2024.102174_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkp040","article-title":"Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells","volume":"37","author":"Haraguchi","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2024.102174_bib30","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1261\/rna.034850.112","article-title":"Potent microRNA suppression by RNA Pol II-transcribed \u2018Tough Decoy' inhibitors","volume":"19","author":"Bak","year":"2013","journal-title":"RNA"},{"key":"10.1016\/j.omtn.2024.102174_bib31","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nmeth.1903","article-title":"Long-term, efficient inhibition of microRNA function in mice using rAAV vectors","volume":"9","author":"Xie","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtn.2024.102174_bib32","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1089\/hum.2008.123","article-title":"Adeno-associated virus (AAV) serotype 9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and rat","volume":"19","author":"Bish","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2024.102174_bib33","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1161\/01.RES.0000237661.18885.f6","article-title":"Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in\u00a0vivo","volume":"99","author":"Pacak","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.omtn.2024.102174_bib34","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1113\/JP270201","article-title":"Genetic disruption of Smad7 impairs skeletal muscle growth and regeneration","volume":"593","author":"Cohen","year":"2015","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.omtn.2024.102174_bib35","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jns.2007.08.029","article-title":"Haploinsufficiency of utrophin gene worsens skeletal muscle inflammation and fibrosis in mdx mice","volume":"264","author":"Zhou","year":"2008","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.omtn.2024.102174_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117306","article-title":"Skeletal muscle fibrosis in the mdx\/utrn+\/- mouse validates its suitability as a murine model of Duchenne muscular dystrophy","volume":"10","author":"Gutpell","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2024.102174_bib37","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0092-8674(00)80533-4","article-title":"Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy","volume":"90","author":"Grady","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2024.102174_bib38","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1161\/CIRCHEARTFAILURE.108.823070","article-title":"Adaptive and maladptive effects of SMAD3 signaling in the adult heart after hemodynamic pressure overloading","volume":"2","author":"Divakaran","year":"2009","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.omtn.2024.102174_bib39","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1097\/01.ASN.0000014252.37680.E4","article-title":"Smad7 inhibits fibrotic effect of TGF-Beta on renal tubular epithelial cells by blocking Smad2 activation","volume":"13","author":"Li","year":"2002","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.omtn.2024.102174_bib40","doi-asserted-by":"crossref","DOI":"10.1172\/JCI146926","article-title":"Smad7 effects on TGF-beta and ErbB2 restrain myofibroblast activation and protect from postinfarction heart failure","volume":"132","author":"Humeres","year":"2022","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtn.2024.102174_bib41","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/mt.2012.251","article-title":"Smad7 suppresses renal fibrosis via altering expression of TGF-beta\/Smad3-regulated microRNAs","volume":"21","author":"Chung","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2024.102174_bib42","first-page":"549","article-title":"Localisation of transforming growth factor beta1 and beta3 mRNA transcripts in normal and fibrotic human lung","volume":"56","author":"Coker","year":"2001","journal-title":"Thorax"},{"key":"10.1016\/j.omtn.2024.102174_bib43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","article-title":"Duchenne muscular dystrophy","volume":"7","author":"Duan","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.omtn.2024.102174_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa7322","article-title":"Immune-mediated pathology in Duchenne muscular dystrophy","volume":"7","author":"Rosenberg","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtn.2024.102174_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-73315-6","article-title":"Cellular senescence-mediated exacerbation of Duchenne muscular dystrophy","volume":"10","author":"Sugihara","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2024.102174_bib46","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1006\/mthe.2002.0675","article-title":"Immune response to full-length dystrophin delivered to Dmd muscle by a high-capacity adenoviral vector","volume":"6","author":"Gilchrist","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2024.102174_bib47","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13395-015-0064-4","article-title":"Differential myofiber-type transduction preference of adeno-associated virus serotypes 6 and 9","volume":"5","author":"Riaz","year":"2015","journal-title":"Skeletal Muscle"},{"key":"10.1016\/j.omtn.2024.102174_bib48","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1111\/1440-1681.12453","article-title":"Targeting transgene to the heart and liver with AAV9 by different promoters","volume":"42","author":"Chen","year":"2015","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.omtn.2024.102174_bib49","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.ymthe.2018.01.016","article-title":"Neonatal Systemic AAV-Mediated Gene Delivery of GDF11 Inhibits Skeletal Muscle Growth","volume":"26","author":"Jin","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2024.102174_bib50","doi-asserted-by":"crossref","first-page":"14082","DOI":"10.1073\/pnas.93.24.14082","article-title":"Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein","volume":"93","author":"Kessler","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2024.102174_bib51","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1073\/pnas.94.11.5804","article-title":"Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus","volume":"94","author":"Herzog","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2024.102174_bib52","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/73464","article-title":"Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector","volume":"24","author":"Kay","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtn.2024.102174_bib53","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1006\/mthe.2002.0673","article-title":"Intramuscular administration of recombinant adeno-associated virus 2 alpha-1 antitrypsin (rAAV-SERPINA1) vectors in a nonhuman primate model: safety and immunologic aspects","volume":"6","author":"Song","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2024.102174_bib54","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/mt.2008.87","article-title":"Safety and Efficacy of Regional Intravenous (RI) Versus Intramuscular (IM) Delivery of rAAV1 and rAAV8 to Nonhuman Primate Skeletal Muscle","volume":"16","author":"Toromanoff","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2024.102174_bib55","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.yjmcc.2012.05.002","article-title":"AAV micro-dystrophin gene therapy alleviates stress-induced cardiac death but not myocardial fibrosis in >21-m-old mdx mice, an end-stage model of Duchenne muscular dystrophy cardiomyopathy","volume":"53","author":"Bostick","year":"2012","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.omtn.2024.102174_bib56","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1517\/14712598.2014.866087","article-title":"New developments in the use of gene therapy to treat Duchenne muscular dystrophy","volume":"14","author":"Jarmin","year":"2014","journal-title":"Expet Opin. Biol. Ther."},{"key":"10.1016\/j.omtn.2024.102174_bib57","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.ymthe.2017.11.014","article-title":"miR-25 Tough Decoy Enhances Cardiac Function in Heart Failure","volume":"26","author":"Jeong","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2024.102174_bib58","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.ymthe.2019.12.011","article-title":"Single SERCA2a Therapy Ameliorated Dilated Cardiomyopathy for 18 Months in a Mouse Model of Duchenne Muscular Dystrophy","volume":"28","author":"Wasala","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2024.102174_bib59","article-title":"Dwarf Open Reading Frame (DWORF) Gene Therapy Ameliorated Duchenne Muscular Dystrophy Cardiomyopathy in Aged mdx Mice","volume":"12","author":"Morales","year":"2023","journal-title":"J.\u00a0Am. Heart Assoc."},{"key":"10.1016\/j.omtn.2024.102174_bib60","article-title":"Dysregulation of Calcium Handling in Duchenne Muscular Dystrophy-Associated Dilated Cardiomyopathy: Mechanisms and Experimental Therapeutic Strategies","volume":"9","author":"Law","year":"2020","journal-title":"J.\u00a0Clin. Med."},{"key":"10.1016\/j.omtn.2024.102174_bib61","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.bbadis.2004.12.003","article-title":"Up-regulation of mitogen activated protein kinases in mdx skeletal muscle following chronic treadmill exercise","volume":"1740","author":"Nakamura","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omtn.2024.102174_bib62","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/S0960-9822(01)00397-9","article-title":"Activation of JNK1 contributes to dystrophic muscle pathogenesis","volume":"11","author":"Kolodziejczyk","year":"2001","journal-title":"Curr. Biol."},{"key":"10.1016\/j.omtn.2024.102174_bib63","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1093\/hmg\/ddu270","article-title":"P38alpha MAPK underlies muscular dystrophy and myofiber death through a Bax-dependent mechanism","volume":"23","author":"Wissing","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2024.102174_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2020.113608","article-title":"A systematic approach to quantitative Western blot analysis","volume":"593","author":"Pillai-Kastoori","year":"2020","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.omtn.2024.102174_bib65","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1177\/0192623318803867","article-title":"Considerations for Preclinical Safety Assessment of Adeno-Associated Virus Gene Therapy Products","volume":"46","author":"Assaf","year":"2018","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.omtn.2024.102174_bib66","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jconrel.2019.06.034","article-title":"Reducing off target viral delivery in ovarian cancer gene therapy using a protease-activated AAV2 vector platform","volume":"307","author":"Tong","year":"2019","journal-title":"J.\u00a0Control Release."},{"key":"10.1016\/j.omtn.2024.102174_bib67","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1479-0556-6-13","article-title":"Tissue specific promoters improve specificity of AAV9 mediated transgene expression following intra-vascular gene delivery in neonatal mice","volume":"6","author":"Pacak","year":"2008","journal-title":"Genet. Vaccine Ther."},{"key":"10.1016\/j.omtn.2024.102174_bib68","article-title":"Gene Therapy Advances: A Meta-Analysis of AAV Usage in Clinical Settings","volume":"8","author":"Au","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.omtn.2024.102174_bib69","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41434-019-0105-4","article-title":"Transduction optimization of AAV vectors for human gene therapy of glaucoma and their reversed cell entry characteristics","volume":"27","author":"Rodriguez-Estevez","year":"2020","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtn.2024.102174_bib70","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12985-021-01555-7","article-title":"Optimization of AAV vectors to target persistent viral reservoirs","volume":"18","author":"Col\u00f3n-Thillet","year":"2021","journal-title":"Virol. J."},{"key":"10.1016\/j.omtn.2024.102174_bib71","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1161\/CIRCRESAHA.114.301798","article-title":"MicroRNA regulation and cardiac calcium signaling: role in cardiac disease and therapeutic potential","volume":"114","author":"Harada","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.omtn.2024.102174_bib72","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-pharmtox-011613-135957","article-title":"microRNA therapeutics in cardiovascular disease models","volume":"54","author":"Dangwal","year":"2014","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.omtn.2024.102174_bib73","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/joim.12298","article-title":"The emerging role of microRNAs in cardiovascular disease","volume":"276","author":"Maegdefessel","year":"2014","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.omtn.2024.102174_bib74","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009008","article-title":"MicroRNAs as therapeutic targets and biomarkers of cardiovascular disease","volume":"6","author":"Olson","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtn.2024.102174_bib75","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nature09783","article-title":"Pervasive roles of microRNAs in cardiovascular biology","volume":"469","author":"Small","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2024.102174_bib76","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/nprot.2008.138","article-title":"Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats","volume":"3","author":"Pacher","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.omtn.2024.102174_bib77","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.yjmcc.2012.03.005","article-title":"PICOT increases cardiac contractility by inhibiting PKCzeta activity","volume":"53","author":"Oh","year":"2012","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.omtn.2024.102174_bib78","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3389\/fneur.2017.00337","article-title":"Evaluation of Functional Correlation of Task-Specific Muscle Synergies with Motor Performance in Patients Poststroke","volume":"8","author":"Li","year":"2017","journal-title":"Front. Neurol."}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253124000611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253124000611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T18:47:05Z","timestamp":1717699625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253124000611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":78,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2162253124000611"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2024.102174","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of miR-25 ameliorates cardiac and skeletal muscle dysfunction in aged mdx\/utrn haploinsufficient (+\/\u2212) mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2024.102174","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"102174"}}